6533b7dafe1ef96bd126d86b

RESEARCH PRODUCT

Antigen carbohydrate 125 and brain natriuretic peptide serial measurements for risk stratification following an episode of acute heart failure.

subject

description

Abstract Background The prognostic utility of combining serial measurements of brain natriuretic peptide (BNP) and antigen carbohydrate 125 (CA125) is largely unknown. The aim of this work is to assess the prognostic utility of serial measurements of BNP, CA125, and their optimal combination for predicting long-term mortality, following a hospitalization for acute heart failure (AHF). Methods and results We analyzed 293 consecutive patients admitted with AHF where CA125 and BNP were measured at discharge (T1) and at the first ambulatory visit (T2: median 31days after discharge). Biomarkers were evaluated as snapshot determinations or as serial changes in absolute, relative or categorical changes and related to subsequent mortality with Cox regression analysis. The incremental prognostic value added by each biomarker was evaluated by the integrated discrimination improvement (IDI) index. During a median follow-up of 18months, 91 deaths (31.1%) were identified. From the different metrics tested, the categorical changes in CA125 (Normalization: decreasing to≤35U/ml at T2; Decreasing but not normalization: decreasing but T2>35U/ml; small-increase: increasing but T2≤35U/ml and; high-increase: increasing and T2>35U/ml) showed the best discriminative accuracy. For BNP none of the serial changes metrics tested were superior to a single determination at T2 (BNP≥100pg/ml). Adding these two biomarkers characterization to the clinical model, resulted in a 9.21% ( p Conclusions In patients discharged for AHF, CA125 modeled as a pre–post categorical change, and BNP as a single determination at T2, resulted in the best marker combination for predicting all-cause mortality.